EF
CRL icon

Empirical Finance’s Charles River Laboratories CRL Stock Holding History

Empirical Finance’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
1,469
+62
+4% +$11K 0.01% 475
2026
Q1 		$243K Sell
1,407
-2
-0.1% -$371 0.01% 468
2025
Q4 		$281K Sell
1,409
-63
-4% -$11.4K 0.01% 458
2025
Q3 		$230K Buy
1,472
+18
+1% +$2.86K 0.01% 498
2025
Q2 		$221K Buy
1,454
+12
+0.8% +$1.6K 0.01% 499
2025
Q1 		$217K Buy
1,442
+133
+10% +$22.3K 0.01% 494
2024
Q4 		$242K Sell
1,309
-1
-0.1% -$193 0.01% 486
2024
Q3 		$258K Buy
1,310
+53
+4% +$11K 0.02% 489
2024
Q2 		$260K Sell
1,257
-15
-1% -$3.4K 0.02% 481
2024
Q1 		$345K Buy
1,272
+64
+5% +$15.3K 0.02% 474
2023
Q4 		$286K Buy
1,208
+29
+2% +$5.7K 0.02% 488
2023
Q3 		$231K Buy
1,179
+188
+19% +$38.6K 0.02% 502
2023
Q2 		$208K Buy
+991
New +$197K 0.02% 502

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Empirical Finance's CRL Position: Q2 2026 in Review

Empirical Finance increased its Charles River Laboratories (CRL) stake by 4.4% in Q2 2026, buying an estimated $11K and bringing the position to 1,469 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #475.

Empirical Finance first reported a position in CRL in Q2 2023 and has held it in 13 quarters since. The position peaked at $345K in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Empirical Finance held 1,469 shares of Charles River Laboratories worth $333K as of Q2 2026.
  • Empirical Finance bought 62 Charles River Laboratories shares in Q2 2026, an estimated $11K.
  • Charles River Laboratories made up 0.01% of Empirical Finance's portfolio in Q2 2026, its #475 holding.
  • Empirical Finance first reported a position in Charles River Laboratories in Q2 2023 and has held it in 13 quarters since.
  • Empirical Finance's Charles River Laboratories position peaked at $345K in Q1 2024.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.